We use cookies and similar technologies for analytics, to understand how the site is used. You can accept or decline non-essential cookies. See our Privacy Policy.
Daily historical data with per-account defaults
Filings, earnings, research, and institutional changes — newest first
신규 편입 · 포트폴리오 비중 0.00%
US analyst rating / recommendation change.
예정된 실적 발표입니다. 일정과 시장 기대치를 확인하세요.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
Consensus vs. actual, and revenue trend
Consensus PT $24.67 · 9 analysts
Stored first · Google News · Yahoo Finance (English)
OrthoPediatrics Corp. to Report Second Quarter Financial Results on August 4, 2026 - Yahoo Finance
OrthoPediatrics Corp. to Report Second Quarter Financial Results on August 4, 2026 Yahoo Finance
OrthoPediatrics Corp. to Report Second Quarter Financial Results on August 4, 2026
Precision Trading with Orthopediatrics Corp. (KIDS) Risk Zones - Stock Traders Daily
Precision Trading with Orthopediatrics Corp. (KIDS) Risk Zones Stock Traders Daily
Earnings Preview: OrthoPediatrics (KIDS) Q3 Earnings Expected to Decline - MSN
Earnings Preview: OrthoPediatrics (KIDS) Q3 Earnings Expected to Decline MSN
Truist Securities Adjusts Price Target on OrthoPediatrics to $20 From $17, Maintains Hold Rating - Moomoo
Truist Securities Adjusts Price Target on OrthoPediatrics to $20 From $17, Maintains Hold Rating Moomoo
Truist Securities Adjusts Price Target on OrthoPediatrics to $20 From $17, Maintains Hold Rating
| Quarter | Date | Time | EPS est. | EPS actual | Surprise | Rev. est. | Rev. actual | Status |
|---|---|---|---|---|---|---|---|---|
| — | 2026. 04. 30. | After market close (AMC) | $-0.28 | — | — | $68.22M | — | Scheduled |
| FY2026 Q1 | 2025. 03. 31. | Time TBD | — | $-0.46 | — | — | $52.41M | Reported |
| FY2025 Q3 | 2024. 09. 30. | Time TBD | — | $-0.94 | — | — | $152.06M | Reported |
| FY2025 Q2 | 2024. 06. 30. | Time TBD | — | $-0.6 | — | — | $97.49M | Reported |
| Date | Firm | Analyst | Action | Rating change | Price target | Report |
|---|---|---|---|---|---|---|
| 2026. 05. 01. | BTIG | — | Maintain | Buy → Buy | — | BTIG: Buy |
| 2026. 03. 02. | Truist Securities | — | Maintain | Hold → Hold | — | Truist Securities: Hold |
| 2026. 02. 27. | Needham | — | Maintain | Buy → Buy | — | Needham: Buy |
| 2026. 02. 27. | BTIG | — | Maintain | Buy → Buy | — | BTIG: Buy |
| 2026. 01. 27. | TD Cowen | — | Initiate coverage | — → Buy | — | TD Cowen: Buy |
| 2025. 12. 10. | Canaccord Genuity | — | Initiate coverage | — → Buy | — | Canaccord Genuity: Buy |
As of FY2026Q1 · Source: SEC/DART + price data
| # | Institution | Mandate | Shares | Value | Weight | Change | Position |
|---|---|---|---|---|---|---|---|
| 1 | Point72 Asset Management, L.P. | Point72 Asset Management, L.P. | 35,933 | $570.26K | 0.00% | — | New position |
| 2 | Point72 Asset Management, L.P. | Point72 Asset Management, L.P. | 30,379 | $539.53K | 0.00% | — | New position |